This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Ardea Biosciences, Inc. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Alex Adjei: Innovator in Cancer Treatment
Introduction
Alex Adjei is a prominent inventor based in Williamsville, NY (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compositions.
Latest Patents
Adjei holds a patent for "Combinations of MEK inhibitors and Raf kinase inhibitors and uses thereof." This invention focuses on the combinations of inhibitors targeting MEK, Raf protein kinases, and other kinases, including VEGFR1-3 and PDGFR-β. The patent outlines pharmaceutical compositions that incorporate these compounds and methods for their use in treating and preventing cancer and other hyperproliferative disorders. He has 1 patent to his name.
Career Highlights
Alex Adjei is associated with Ardea Biosciences, Inc., where he continues to advance his research in oncology. His work has been instrumental in developing new therapeutic strategies for cancer treatment.
Collaborations
Throughout his career, Adjei has collaborated with notable colleagues, including Jeffrey Miner and Mark Chapman. Their combined expertise has contributed to the success of various projects within the company.
Conclusion
Alex Adjei's innovative work in the field of cancer treatment exemplifies the impact of dedicated research and collaboration in advancing medical science. His contributions continue to pave the way for new therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile